Skip to main content

Global Conference registration is open! Join thought leaders, May 5–8, 2024, in shaping a shared future through discussions on global issues, innovation, and collective progress.

Innovation Versus Access to Medicines: Can We Have Both?

2023 Global Conference

Innovation Versus Access to Medicines: Can We Have Both?

Monday, May 1, 2023
10:00 AM - 11:00 AM PDT
Beverly Hilton - Dayton

The balance between medical innovation and access to the products of that innovation has always been challenging. It’s imperative to strike a balance as the cost of innovations such as cell and gene therapies climbs exponentially, more personalized medicine and prevention becomes possible, and the need to address inequities in access and outcomes rises to the global forefront. As science progresses towards cracking the codes of scourges such as cancer, Alzheimer’s, and infectious diseases, who bears the responsibility to ensure that people in need are able to benefit? 

Mark McClellan
Director, Duke-Margolis Center for Health Policy, Duke University
Louis DeGennaro
President and CEO, Leukemia & Lymphoma Society
Johanna Mercier
Chief Commercial Officer, Gilead Sciences
Jen Miller
Professor, Yale School of Medicine; CEO, Bioethics International
David Tapolczay
CEO, St George Street Capital
Andrea Willis
Senior Vice President and Chief Medical Officer, BlueCross BlueShield of Tennessee